Infliximab Concept

subject area of

• 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis  Journal Articles
• A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease  Journal Articles
• Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: An indirect treatment comparison meta-analysis  Journal Articles
• American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis  Journal Articles
• Anti-TNFα therapy in immune-mediated subfertility: State of the art  Journal Articles
• Anti-cytokine targeted therapies for ANCA-associated vasculitis  Journal Articles
• Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn’s Disease  Journal Articles
• Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis  Journal Articles
• Biologic survival.  Journal Articles
• Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease  Journal Articles
• Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease  Journal Articles
• Changes in the gut microbiome associated with infliximab in patients with bipolar disorder  Journal Articles
• Clinical Decision Support Tool for Infliximab in Crohn’s Disease  Journal Articles
• Combination Therapy With Methotrexate in Inflammatory Bowel Disease: Time to COMMIT?  Journal Articles
• Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease  Conferences
• Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease  Journal Articles
• Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis  Journal Articles
• Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study  Journal Articles
• Comparative Efficacy of Infliximab vs Ustekinumab for Maintenance of Clinical Response in Biologic Naïve Crohn’s Disease  Journal Articles
• Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis  Journal Articles
• Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs  Journal Articles
• Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis  Journal Articles
• Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?  Journal Articles
• Editorial: methotrexate in patients with Crohn's disease refractory to anti‐TNF therapy—moving backwards yet forward?  Journal Articles
• Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn’s Disease: A Systematic Review and Pooled Meta-analysis  Journal Articles
• Effectiveness of Tofacitinib for Hospitalized Patients with Acute Severe Ulcerative Colitis: Case Series  Journal Articles
• Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis  Journal Articles
• End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn’s Disease  Journal Articles
• Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab  Journal Articles
• Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management survey  Journal Articles
• Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn’s disease patients  Journal Articles
• Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis  Journal Articles
• Improvement of Lumbar Bone Mass after Infliximab Therapy in Crohn’s Disease Patients  Journal Articles
• Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors  Journal Articles
• Infliximab as a second‐line therapy for children with refractory Kawasaki disease: A systematic review and meta‐analysis of randomized controlled trials  Journal Articles
• Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.  Journal Articles
• Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis  Journal Articles
• Infliximab‐Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL‐23 Receptor Polymorphisms  Journal Articles
• Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease – should one consider disease location? Authors’ reply  Journal Articles
• Lewis–Sumner syndrome associated with infliximab therapy in rheumatoid arthritis  Journal Articles
• Meta‐analysis: peri‐operative anti‐TNFα treatment and post‐operative complications in patients with inflammatory bowel disease  Journal Articles
• Nail Psoriasis and Biologics  Journal Articles
• Occurrence of Plantar Pustular Psoriasis during Treatment with Infliximab  Journal Articles
• Outcomes Following Acute Severe Colitis at Initial Presentation: A Multi-centre, Prospective, Paediatric Cohort Study  Journal Articles
• Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn’s Disease: A Post-hoc Analysis  Journal Articles
• Patient outcomes after anti TNF-α drugs for Crohn’s disease  Journal Articles
• Peripheral inflammatory biomarkers define biotypes of bipolar depression  Journal Articles
• Practical Understanding of Mean Percent Psoriasis Area and Severity Index Reduction for Biologics  Journal Articles
• Pragmatic pharmacoeconomic analyses by using post-market adverse drug reaction reports: an illustration using infliximab, adalimumab, and the Canada vigilance adverse reaction database  Journal Articles
• Prevalence of endoscopic improvement and remission according to patient‐reported outcomes in ulcerative colitis  Journal Articles
• Refractory Primary Central Nervous System Vasculitis of Childhood: Successful Treatment with Infliximab  Journal Articles
• Resource utilization during pediatric to adult transfer of care in IBD  Journal Articles
• Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis  Journal Articles
• Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease  Journal Articles
• Review article: dose optimisation of infliximab for acute severe ulcerative colitis  Journal Articles
• Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids  Journal Articles
• The Effects of a Monoclonal Antibody Directed against Tumor Necrosis Factor-α in Asthma  Journal Articles
• The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn’s Disease  Conferences
• The Safety of Infliximab Infusions in the Community Setting  Journal Articles
• The efficacy and safety of either infliximab or adalimumab in 362 patients with anti‐TNF‐α naïve Crohn's disease  Journal Articles
• The incidence of inflammatory bowel disease in the pediatric population of Southwestern Ontario  Journal Articles
• Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements  Journal Articles
• Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease  Journal Articles